Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1982 Aug;70(2):453–460. doi: 10.1172/JCI110635

Bence Jones proteins and light chains of immunoglobulins. Preferential association of the V lambda VI subgroup of human light chains with amyloidosis AL (lambda).

A Solomon, B Frangione, E C Franklin
PMCID: PMC371254  PMID: 6808027

Abstract

An antiserum prepared against a lambda-Bence Jones protein from a patient (SUT) who had multiple myeloma and amyloidosis had specificity for lambda-light chains of the chemically defined variable (V) region lambda-chain subgroup lambda VI. Sequence analyses of protein SUT and of five other lambda-light chains recognized immunologically as of the V lambda VI subgroup revealed that all six proteins had the N-terminal sequence characteristic for prototype lambda VI proteins. The isotypic nature of the V lambda VI subgroup was demonstrated immunochemically: lambda VI molecules were detected among light chains isolated from the IgG proteins of each of 12 normal individuals and lambda VI antigenic determinants were also detectable on the intact IgG proteins. The frequency of lambda VI molecules among lambda-type light chains is estimated to be approximately 5% based on the finding that 5 of 91 lambda Bence Jones proteins were of the V lambda VI subgroup. Proteins of the V lambda VI subgroup, in contrast to those of the other five chemically-classified lambda chain subgroup, appear to be preferentially associated with the amyloid process as evidenced by the fact that all six lambda VI proteins were obtained from patients with amyloidosis AL and, in addition, 5 of 42 lambda-type monoclonal immunoglobulins from patients with primary or myeloma-associated amyloidosis were classified by immunodiffusion analyses as having lambda VI-type light chains.

Full text

PDF
453

Images in this article

454Image
on p.454
457Image
on p.457
457Image
on p.457
458Image
on p.458
458Image
on p.458

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraham G. N., Podell D. N., Wistar R., Jr, johnston S. L., Welch E. H. Immunological and structural properties of human monoclonal IgG cryoglobulins. Clin Exp Immunol. 1979 Apr;36(1):63–70. [PMC free article] [PubMed] [Google Scholar]
  2. Bentley D. L., Rabbitts T. H. Human V kappa immunoglobulin gene number: implications for the origin of antibody diversity. Cell. 1981 Jun;24(3):613–623. doi: 10.1016/0092-8674(81)90088-x. [DOI] [PubMed] [Google Scholar]
  3. Glenner G. G. Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts). N Engl J Med. 1980 Jun 5;302(23):1283–1292. doi: 10.1056/NEJM198006053022305. [DOI] [PubMed] [Google Scholar]
  4. Glenner G. G., Harada M., Isersky C. The purification of amyloid fibril proteins. Prep Biochem. 1972;2(1):39–51. doi: 10.1080/00327487208061451. [DOI] [PubMed] [Google Scholar]
  5. Glenner G. G., Terry W. D., Isersky C. Amyloidosis: its nature and pathogenesis. Semin Hematol. 1973 Jan;10(1):65–86. [PubMed] [Google Scholar]
  6. McLaughlin C. L., Solomon A. Bence-Jones proteins and light chains of immunoglobulins. VII. Localization of antigenic sites responsible for immunochemical heterogeneity of kappa chains. J Biol Chem. 1972 Aug 25;247(16):5017–5025. [PubMed] [Google Scholar]
  7. Michaelsen T. E., Frangione B., Franklin E. C. Primary structure of the "hinge" region of human IgG3. Probable quadruplication of a 15-amino acid residue basic unit. J Biol Chem. 1977 Feb 10;252(3):883–889. [PubMed] [Google Scholar]
  8. Natvig J. B., Westermark P., Sletten K., Husby G., Michaelsen T. Further structural and antigenic studies of light-chain amyloid proteins. Scand J Immunol. 1981 Jul;14(1):89–94. doi: 10.1111/j.1365-3083.1981.tb00187.x. [DOI] [PubMed] [Google Scholar]
  9. Pras M., Schubert M., Zucker-Franklin D., Rimon A., Franklin E. C. The characterization of soluble amyloid prepared in water. J Clin Invest. 1968 Apr;47(4):924–933. doi: 10.1172/JCI105784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Skinner M., Benson M. D., Cohen A. S. Amyloid fibril protein related to immunoglobulin lambda-chains. J Immunol. 1975 Apr;114(4):1433–1435. [PubMed] [Google Scholar]
  11. Sletten K., Husby G., Natvig J. B. N-terminal amino acid sequence of amyloid fibril protein AR, prototype of a new lambda-variable subgroup, V lambda V. Scand J Immunol. 1974;3(6):833–836. doi: 10.1111/j.1365-3083.1974.tb01319.x. [DOI] [PubMed] [Google Scholar]
  12. Sletten K., Natvig J. B., Husby G., Juul J. The complete amino acid sequence of a prototype immunoglobulin-lambda light-chain-type amyloid-fibril protein AR. Biochem J. 1981 Jun 1;195(3):561–572. doi: 10.1042/bj1950561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Solomon A. Bence Jones proteins and light chains of immunoglobulins. XIV. Conformational dependency and molecular localization of the kappa (kappa) and lambda (lambda) antigenic determinants. Scand J Immunol. 1976;5(6-7):685–695. doi: 10.1111/j.1365-3083.1976.tb03018.x. [DOI] [PubMed] [Google Scholar]
  14. Solomon A. Bence-Jones proteins and light chains of immunoglobulins (first of two parts). N Engl J Med. 1976 Jan 1;294(1):17–23. doi: 10.1056/NEJM197601012940105. [DOI] [PubMed] [Google Scholar]
  15. Solomon A., McLaughlin C. L. Bence-Jones proteins and light chains of immunoglobulins. I. Formation and characterization of amino-terminal (variant) and carboxyl-terminal (constant) halves. J Biol Chem. 1969 Jun 25;244(12):3393–3404. [PubMed] [Google Scholar]
  16. Solomon A., Schmidt W., Havemann K. Bence Jones proteins and light chains of immunoglobulins. XIII. Effect of elastase-like and chymotrypsin-like neutral proteases derived from human granulocytes on Bence Jones proteins. J Immunol. 1976 Sep;117(3):1010–1014. [PubMed] [Google Scholar]
  17. Takahashi N., Takayasu T., Isobe T., Shinoda T., Okuyama T., Shimizu A. Comparative study on the structure of the light chains of human immunoglobulins. II. Assignment of a new subgroup. J Biochem. 1979 Nov;86(5):1523–1535. doi: 10.1093/oxfordjournals.jbchem.a132670. [DOI] [PubMed] [Google Scholar]
  18. Terry W. D., Page D. L., Kimura S., Isobe T., Osserman E. F., Glenner G. G. Structural identity of Bence Jones and amyloid fibril proteins in a patient with plasma cell dyscrasia and amyloidosis. J Clin Invest. 1973 May;52(5):1276–1281. doi: 10.1172/JCI107295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Tischendorf F. W., Tischendorf M. M., Osserman E. F. Subgroup-specific antigenic marker on immunoglobulin lambda chains: identification of three subtypes of the variable region. J Immunol. 1970 Oct;105(4):1033–1035. [PubMed] [Google Scholar]
  20. Wang A. C., Fudenberg H. H., Wang I. Y., Watanabe A. Chemical and genetic characterization of a monoclonal IgA(lambda) protein with both cryo- and pyro-precipitability. Scand J Immunol. 1976;5(4):311–316. doi: 10.1111/j.1365-3083.1976.tb00284.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES